Core Insights - Synopsys, Inc. reported stronger-than-expected fourth-quarter results with adjusted earnings of $2.90 per share and revenue of $2.26 billion, slightly above analyst estimates [2] - For fiscal 2026, Synopsys projects adjusted EPS between $14.32 and $14.40 and revenue between $9.56 billion and $9.66 billion, exceeding consensus expectations [2] Analyst Ratings and Forecasts - BofA Securities upgraded Synopsys from Neutral to Buy, raising the price target from $500 to $560 [3] - Rosenblatt maintained a Buy rating with a price target of $560 [3] - JPMorgan reiterated an Overweight rating and increased the price target from $600 to $650 [3] Analyst Commentary - BofA's analyst sees Synopsys as a lower-beta way to gain AI exposure in 2026, noting reduced risk around China and Intel revenue, and strong momentum from Ansys [4] - Rosenblatt's analyst highlighted that fourth-quarter revenue was slightly above expectations, driven by a full quarter contribution from Ansys, which grew about 10% year-over-year [7] - JPMorgan's analyst noted that fiscal 2026 is a "transition year" with guidance implying high-single-digit growth for core EDA and low- to mid-single-digit growth for Design IP [9] Revenue and EPS Projections - Analysts project first-quarter revenue of $2.39 billion and adjusted EPS of $3.55 [6][8][10] - Fiscal revenue expectations are $9.61 billion with adjusted EPS of $14.37 according to BofA, while Rosenblatt expects $9.64 billion and $14.35, and JPMorgan anticipates $9.65 billion and $14.39 [6][8][10] Market Performance - Synopsys stock traded lower by 0.59% at $473.03 at the time of publication [10]

Synopsys, Inc. (NASDAQ:SNPS) posted better-than-expected earnings for the fourth quarter on Wednesday.Synopsys reported quarterly earnings of $2.90 per share, which beat the Street of $2.78. Quarterly revenue came in at $2.26 billion, which beat the analyst estimate of $2.25 billion."The Synopsys team delivered a solid finish to a year that redefined our company as the leader in engineering solutions from silicon to systems," said Sassine Ghazi, CEO of Synopsys.Synopsys sees fiscal 2026 adjusted EPS of $14. ...

Group 1 - Synopsys, Inc. reported fourth-quarter earnings of $2.90 per share, exceeding the analyst expectation of $2.78, with quarterly revenue of $2.26 billion, surpassing the estimate of $2.25 billion [1] - CEO Sassine Ghazi highlighted the company's strong performance, stating it redefined Synopsys as a leader in engineering solutions from silicon to systems [1] Group 2 - For fiscal 2026, Synopsys projects adjusted EPS between $14.32 and $14.40, significantly above the analyst estimate of $12.85, and revenue expectations of $9.56 billion to $9.66 billion, compared to the $7.04 billion estimate [2] - Following the earnings announcement, Synopsys shares fell by 0.8% to $472.13 [2] Group 3 - Piper Sandler analyst Clarke Jeffries maintained an Overweight rating on Synopsys but lowered the price target from $630 to $602 [3] - Needham analyst Charles Shi maintained a Buy rating and raised the price target from $550 to $580 [3] - B of A Securities analyst Vivek Arya upgraded Synopsys from Neutral to Buy, increasing the price target from $500 to $560 [3] - Keybanc analyst Jason Celino maintained an Overweight rating and raised the price target from $575 to $600 [3] - Wells Fargo analyst Joe Quatrochi maintained an Equal-Weight rating and increased the price target from $445 to $500 [3]

智通财经APP获悉，周四，电子设计自动化与IP供应商新思科技(SNPS.US)公布的第四财季业绩及2026 财年展望显示业务趋于稳定，获得多家华尔街机构积极评价及上调目标价。 富国银行则维持"中性"评级，但仍将目标价从445美元上调至500美元。分析师Joe Quatrochi与Travis Poulin认为，公司对2026财年的初步指引"喜忧参半"，Ansys收入预计29亿美元，高于其预期，但意味着 EDA增长可能低于此前设想。他们估计2026财年核心EDA增长为7%至8%，低于此前预测的8.5%，也低 于市场约10%的预期。同时，IP收入仍将维持疲弱。富国银行表示将继续关注公司关键增长驱动，包括 Ansys协同解决方案、Agentic AI发展，以及中国业务基数效应改善为整体增长带来的潜在提速。 Needham亦维持"买入"评级，将目标价从550美元上调至580美元。分析师Charles Shi与Denis Pyatchanin 指出，公司对2026财年第一季度的指引略低于市场预期，但对于财年末发布业绩的公司来说，"来年的 指引才是投资者关注的核心"。他们认为市场先前预期公司在完成大型并购后会给出较为艰难 ...

Core Viewpoint - The report summarizes significant rating changes from various investment firms that are expected to impact the market. Upgraded Ratings - Jefferies upgraded Roku (ROKU) from "Hold" to "Buy," raising the target price from $100 to $135, anticipating over 20% growth in platform revenue under optimistic scenarios [5] - Piper Sandler upgraded Unity (U) from "Neutral" to "Outperform," increasing the target price from $43 to $59, citing a favorable outlook for the mobile app advertising market entering 2026 [5] - Citigroup upgraded Thermo Fisher Scientific (TMO) from "Neutral" to "Buy," raising the target price from $580 to $660, expecting benefits from increased pharmaceutical spending and local industry advantages [5] - Bank of America upgraded Synopsys (SNPS) from "Neutral" to "Buy," increasing the target price from $500 to $560, noting reduced risks in sales to China and Intel, and potential for attractive rebound [5] - Bank of America upgraded Visa (V) from "Neutral" to "Buy," setting a target price of $382, indicating attractive return potential after recent underperformance [5] Downgraded Ratings - Bank of America downgraded PayPal (PYPL) from "Buy" to "Neutral," lowering the target price from $93 to $68, citing delays in revitalizing core payment business growth [5] - Harbor Research downgraded General Electric Energy (GEV) from "Buy" to "Neutral," without providing a target price, stating current valuation is reasonable [5] - Bank of America downgraded Alcon (ALC) from "Buy" to "Underperform," reducing the target price from $100 to $75, due to limited upside and market uncertainties [5] - Deutsche Bank downgraded Norfolk Southern Railway (NSC) from "Buy" to "Hold," setting a target price of $297, attributing the downgrade to unresolved merger issues with Union Pacific Railway (UNP) [5] - Deutsche Bank downgraded Union Pacific Railway from "Buy" to "Hold," setting a target price of $245, despite strong performance over two quarters, citing poor stock performance [5] Initiated Coverage - Freedom Capital initiated coverage on Shift4 Payments (FOUR) with a "Buy" rating and a target price of $80, viewing recent pullbacks as an attractive entry point [5] - Bernstein initiated coverage on BridgeBio Pharma (BBIO) with an "Outperform" rating and a target price of $94, suggesting that short-term expectations are reasonable but long-term may be overly optimistic [5] - B. Riley initiated coverage on Chime Bank (CHYM) with a "Buy" rating and a target price of $35, indicating a 40% potential upside, highlighting its profitable and high-growth digital banking services [5] - Morgan Stanley initiated coverage on Elbit Systems (ESLT) with a "Hold" rating and a target price of $531, noting that most growth potential is already reflected in the current stock price after a 95% increase this year [5] - Goldman Sachs initiated coverage on Abercrombie & Fitch (ANF) with a "Buy" rating and a target price of $120, favoring companies with store expansion capabilities and pricing power in the apparel retail sector [5]

Synopsis - Synopsis reported adjusted EPS of 290, beating the expected 278, with revenue of 2.4 billion, slightly above the anticipated 2.24 billion [2][4] - The company achieved record full-year performance with fiscal 2025 revenue reaching 7.1 billion, a 15% increase from fiscal 2024 [4] - The backlog stood at 11.4 billion, and the CFO anticipates another revenue record in 2026 [4] - The ANCIS acquisition contributed 2.9 billion in revenue, impacting Q4 results [5] - Analysts are optimistic, with Morgan Stanley raising its price target to 550 from 510, Bank of America upgrading to a buy with a target of 560, and JP Morgan Chase increasing its target to 650 [6][7] Alphabet (Google) - Alphabet has been a strong performer in the MAG 7, with Piper Sandler reiterating an overweight rating and raising the price target from 330 to 365 [8][9] - The increase reflects stronger fundamentals and improved ad buyer sentiment, with Google search gaining digital ad budget share for the first time in three years [9][10] - The latest iteration of Gemini is performing well, and both Performance Max and Gemini are driving incremental revenue and enhancing advertiser insights [11][12] Eli Lilly - Eli Lilly reported positive trial results for its next-generation weight loss drug, showing patients lost about 25% of their weight over 68 weeks [14][15] - The drug targets conditions linked to obesity, reinforcing Eli Lilly's position in a market projected to reach 100 billion by 2030 [15] - Eli Lilly has been outperforming competitors like Novartis in the obesity treatment sector [16]

Upgrades Summary - Jefferies upgraded Roku (ROKU) to Buy from Hold with a price target of $135, increased from $100, anticipating over 20% platform revenue growth in an upside scenario [2] - Piper Sandler upgraded Unity (U) to Overweight from Neutral with a price target of $59, up from $43, citing a healthy mobile app advertising market entering 2026; BTIG also upgraded Unity to Buy from Neutral with a $60 price target [2] - Citi upgraded Thermo Fisher (TMO) to Buy from Neutral with a price target of $660, raised from $580, expecting benefits from increased pharmaceutical spending and onshoring trends [2] - BofA upgraded Synopsys (SNPS) to Buy from Neutral with a price target of $560, up from $500, arguing that the company's solid FY26 guidance mitigates risks related to China and Intel sales, presenting attractive stock catch-up potential and EPS beats for the next year [2] - BofA upgraded Visa (V) to Buy from Neutral with a price target of $382, believing that Visa shares present very attractive return potential following recent underperformance [2]

Core Insights - Nvidia has purchased $2 billion of Synopsys stock and plans to enhance their existing partnership to improve product upgrades and cloud utilization [1][2] - The partnership aims to revolutionize the design and engineering industry, which is highly compute-intensive [3] Company Performance - Synopsys shares rose 2.01% in the five days ending December 10, but have dropped 1.96% year-to-date [4] - Synopsys has a market capitalization of $86.5 billion, with a trailing price-to-sales ratio of 48.3x and a price-to-book ratio of 2.6x [5] Financial Results - For the year ending in July, Synopsys reported earnings per share (EPS) of $9.60 [6] - In the fiscal third quarter, revenue was $892.36 million, an increase from $803.15 million year-over-year, but operating income fell to $165.27 million from $360.2 million due to rising costs [6] - The weaker performance of Synopsys's IP business was attributed to new export restrictions in China and challenges with a major foundry customer [7] - Despite these challenges, the company anticipates record revenue for the current fiscal year, partly due to the acquisition of Ansys, which closed in July [7][8]

Core Viewpoint - Top Wall Street analysts have revised their outlook on several prominent companies, indicating a shift in market sentiment and potential investment opportunities [1] Group 1: Analyst Ratings Changes - The article highlights changes in analyst ratings, including upgrades, downgrades, and initiations for various stocks [1] - Specific mention of SNPS stock suggests it is under consideration for potential investment based on analyst opinions [1]

Group 1 - Synopsys, the leading global EDA software provider, reported strong earnings driven by robust demand for AI and HPC, with Q4 revenue increasing by 37.8% year-over-year to $2.26 billion, slightly above market expectations of $2.25 billion [2] - Adjusted earnings per share for Q4 were $2.90, lower than $3.40 in the same quarter of 2024 but exceeding Wall Street's estimate of $2.78 [2] - The Design Automation segment, responsible for semiconductor design software, saw a revenue growth of 65%, rising from $1.12 billion in Q4 2024 to $1.85 billion, accounting for 80% of total revenue, indicating sustained demand for EDA tools driven by AI chip design [2] Group 2 - For Q1 of the 2026 fiscal year, Synopsys forecasts revenue between $2.36 billion and $2.42 billion, with the midpoint exceeding Wall Street's expectation of $2.38 billion, and adjusted earnings per share projected between $3.52 and $3.58, also above the average estimate of $3.36 [3] - Major tech companies are accelerating investments in self-developed AI chips to reduce operational costs, relying on EDA software to streamline complex IC design processes, which is driving strong order momentum for Synopsys [3] - NVIDIA announced a $2 billion investment in Synopsys to collaborate on accelerating computing and AI engineering innovations, attracting significant industry attention [3]